The Clicks Group has announced plans to sell its shareholding in its pharmaceutical manufacturing subsidiary, Unicorn Pharmaceuticals. The sale is anticipated to be finalised by the end of July. This decision follows the Constitutional Court’s ruling in March 2023 in the Independent Community Pharmacy Association’s case against the Clicks Group case. Subsequently, the matter was referred to the director-general of…